PacBio's (PACB) new offering, PanDNA kit, is likely to help researchers effectively extract DNA optimized for HiFi sequencing. This versatile Nanobind kit is expected to be available in February 2024.

Pacific BioSciences' DNA sequencer might have been the Hubble Telescope of biology. But in this case, the key fix that will allow it to see with unheard-of clarity may have come years too late.

The licensed technology is designed to enhance PacBio HiFi sequencing with improved detection of DNA base modifications—including 5-hydroxymethylcytosine (5hmC) and hemimethylated 5 ...

DENVILLE, N.J. and LIÈGE, Belgium, March 12, 2019 /PRNewswire-PRWeb/ -- Diagenode, a leading global provider for complete solutions for sample preparation and epigenetics research, has launched ...

--PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced PanDNA, a versatile Nanobind DNA extraction kit. "The new PanDNA kit will be the go-to kit for ...

Back in February, PacBio forecasted 2024’s full-year revenues to land between $230 million to $250 million, for 15% to 25% beyond 2023’s haul of just over $200 million.

PacBio describes the sequencer as an improvement over its current high-capacity Sequel IIe long-read hardware. Though both rely on what the company has dubbed HiFi sequencing, the Revio includes a ...

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently announced PanDNA, a versatile Nanobind DNA extraction kit. With the addition of this new offering, the range of sample ...

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced PanDNA, a versatile Nanobind DNA extraction kit. This new offering expands the array ...

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently announced PanDNA, a versatile Nanobind DNA extraction kit. With the addition of this new offering, the range of ...